DanCann Pharma A/S announced that the Company on February 1st, opened a sales office centrally in Denmark. The office facilities in the old post office in the center of Odense will in the future form the framework for the Company's commercial activities and work in the regulatory area. Louise Conradsen will become the daily manager of the office in Odense.

She is the CEO of the subsidiary CannGros ApS ("CannGros") and sales manager of DanCann Pharma - and lives almost next door to the new office, located at Lille Gråbrødrestræde 1, 5000 Odense C. Since its founding in 2018, DanCann Pharma has taken huge steps towards establishing itself as a producer and distributor of products on the market for medical cannabis. When the company acquired the wholesale company CannGros in the fall of 2021, DanCann Pharma became the market leader with license and sales rights for three available products on the market under the Danish Pilot Programme. At the end of 2022, DanCann Pharma received its EU-GMP certification from the Danish Medicines Agency and is therefore looking into a future where the commercial aspect will be more in focus.

Both in connection with the sale of own production, but also to a large extent through an upgrading and expansion of the activities in CannGros.